Protein Engineering, Vol. 15, No. 10, 799-804,
October 2002
© 2002 Oxford University Press
Asymmetric conductivity of engineered porins
Institut für Organische Chemie und Biochemie, Albert-Ludwigs-Universität, Albertstrasse 21, D-79104 Freiburg im Breisgau, Germany
| Abstract |
|---|
|
|
|---|
Positively charged peptide segments of 16 and 18 residues were inserted at a periplasmic turn of the porin from Rhodobacter blasticus in order to form an electric field-dependent plug. The X-ray diffraction analysis of a mutant confirmed that the structure of the porin had remained intact and that the insert was mobile. Incorporation experiments of single molecules into lipid bilayers showed that the distribution of electric conduction increments depended on the field polarity. The observed distributions are explained if the porin molecules enter the bilayer preferentially with their periplasmic surface first. Furthermore, the conduction of membrane-incorporated porin mutants changed reproducibly on field reversal showing asymmetries of
15%, while the wild-type remained constant. This asymmetry is most likely caused by the electric field pressing the charged insert onto the pore eyelet in one field direction and removing it from the eyelet in the other. The results encourage attempts to improve the inserts in order to eventually reach diode characteristics.
Keywords: black lipid membrane/ion channels/ion current gating/peptide insert/X-ray diffraction
| Introduction |
|---|
|
|
|---|
Porins form channels across the outer membrane of Gram-negative bacteria that allow for the passive permeation of small polar solutes with an upper Mr limit of
600 Da (Jap and Walian, 1990
|
| Materials and methods |
|---|
|
|
|---|
Design and production of mutants
All inserts were designed to start after Asn203. They were flanked by glycines in order to make them mobile (Van Gelder et al., 1997
). Proline with its high
-helix initiation potential was always used at the first non-glycine position, and Leu, Met, Glu, Lys, Ala, Arg with high
-helix propensities for the following nine positions, hoping that the inserts would form
-helices.
First, gene insB was produced by two PCR runs with two internal and two external primers starting from the plasmid pET-3b-por (Schmid et al., 1996
) that had NdeI and BamHI sites before and after the porin gene. The two internal PCR primers coded for the insert, carried a XhoI restriction site, and overlapped with the porin gene for 19 bases at the 3'-end and 31 bases at the 5'-end. The external primers, each 35 bases long, were located beyond the NdeI and BamHI sites, respectively. The PCR products were cut with NdeI and XhoI, or XhoI and BamHI, respectively, and isolated from a 1% agarose gel using a gel extraction kit (Qiagen, Hilden, Germany). Together, the resulting two DNA fragments were ligated into a pUC18 vector that had been opened with NdeI and BamHI. The correct product was selected from heat-shock-transformed Escherichia coli XL1-Blue cells (Hanahan, 1983
) and transferred into the production vector pET-3b-insB. The genes of mutants InsA through InsE (Figure 1A
) were then produced by a cassette mutagenesis approach using three further restriction sites, NotI, ApaI and MunI, respectively, which were introduced within and near the insert.
The mutant-carrying plasmids were expressed into inclusion bodies in E.coli BL21(DE3)pLysS. All porin mutants carried the additional mutation Glu1
Met that is required for the cytosolic production. The porins were isolated as described (Schmid et al., 1996
), except that urea and superfluous detergent were removed by dialysis against a 10-fold volume of buffer containing 10 mM TrisHCl pH 8.0, 20 mM NaCl and 0.2 mM EDTA in the (re)naturation procedure. The resulting porin was then purified using a Q-Sepharose-FF column. The procedure of Pautsch et al. (Pautsch et al., 1999
) was equally efficient. The protein yields were
20 mg per liter of culture.
Crystallization and X-ray diffraction analysis
Crystals of mutant InsA grew from 50 mM NaOAc pH 4.75, 100 mM (NH4)2SO4, 5.5% PEG-4000, 5 mM octyltetraoxyethylene (C8E4), 12.5 mM decanoyl sucrose and 5 mg/ml of the protein. Diffraction data were collected at room temperature from one crystal using a rotating anode (Rigaku, model RU200B) and an image plate (MARresearch, 30 cm). The data were processed with the programs MOSFLM (Leslie, 1999
) as well as SCALA and TRUNCATE (CCP4, 1994
). The crystal was not merohedrally twinned (Yeates, 1997
). Calculated phases were taken from the wild-type (PDB accession code 1PRN). The structure was refined with a fixed temperature factor using program CNS (Brünger et al., 1998
). The coordinates and structure factors are deposited in the Protein Data Bank under accession code 1H6S.
Conductivity measurements
The purified protein was incorporated into a planar lipid bilayer of diphytanoyl phosphatidyl choline (Avanti Polar Lipids, Alabaster, AL, USA) separating two chambers each filled with 5 ml of buffer (20 mM MOPS titrated with 11 mM Tris to pH 7.2) (Figure 1D
). In order to be consistent with the crystallization conditions, mutant InsA was also measured at pH 4.8 buffered with 20 mM LiOAc. In all experiments, the conducting electrolyte was added to both chambers. A further 1040 µM Triton X-100 applied to the cis chamber (containing the porins) facilitated the incorporation into the bilayer. Each incorporated porin molecule gave rise to an ion current increment of
50 pA that was usually stable and reported electronically.
In our electric field reversal experiments we always used the MOPS buffer at pH 7.2. The electrode connections were reversed with a double switch in such a manner that the current amplifier and the detection apparatus remained unaffected. The electrodes themselves showed an asymmetry of
1 mV which was taken into account when calculating conductivities.
| Results and discussion |
|---|
|
|
|---|
Asn203 in the mobile turn T5 at the periplasmic barrel end was chosen as the insert position, because a disturbance at this turn should not affect the porin structure. Moreover, this position is close to the channel and far from any crystal packing contact (Kreusch and Schulz, 1994
|
In contrast to the well diffracting wild-type crystals grown at pH 7.2 (Kreusch and Schulz, 1994
-helix sketched in Figure 1C
|
|
| Comparison of membrane incorporation out of anode versus cathode chamber |
|---|
|
|
|---|
In two series of experiments we analyzed the behavior of the porin mutants on incorporation into the lipid bilayer. First, we added porin to the chamber with the more positive potential, i.e. the `anode' chamber (cis+) and measured the ionic current steps caused by the incorporation of single porin molecules into the membrane (Figure 1D
|
Obviously, membrane incorporation is affected by the applied electric field. Wild-type porin, and in particular the mutants, contain an electric dipole (Figure 1C
In similar experiments, the cis+ incorporation of wild-type porin and mutants InsA and InsB was repeated with lithium acetate as the electrolyte instead of KCl. The resulting histograms in Figure 5
show a reduction by a factor of five with respect to the KCl conductivity, contrasting the factor of two that is expected from the ion mobility differences in free solution. This deviation reflects the geometric influence of a narrow pore eyelet on the large acetate and hydrated Li+ ions compared with the small K+ and Cl- ions.
|
| Conductivity changes of membrane-incorporated porins on electric field reversal |
|---|
|
|
|---|
In a further series of experiments we added porins to the anode chamber (cis+), waited for the incorporation of as few molecules as possible and then reversed the electric field across the bilayer. The reversal was repeated several times in order to check reproducibility. The cis+ option was applied because in this case the membrane incorporation behavior was much more normal than with cis (Figure 4
Using wild-type porin we observed no conductivity differences on field reversal in any of our experiments. The results for a single incorporated porin molecule (as judged from the observed conductivity of 0.7 nS which fits the distribution of Figure 5A
) are shown in Figure 6A
. Apart from wild-type we used the mutant InsA in a number of trials. Most of them showed clear and reproducible conductivity differences on field reversal. A measurement with more than 10 reversals is shown in Figure 6B
. A further experiment with a reproducible two-step conductivity decrease on field reversal is given in Figure 6C
. Such double steps occurred in several measurements. Asymmetries of similar magnitude were observed in experiments using the other mutants and other salts (data not shown).
|
The observed conductivity differences were plotted against the average conductivity in Figure 7
|
The spread of the conductivity differences shown in Figure 7
| Conclusion |
|---|
|
|
|---|
The designed conduction asymmetry was in fact achieved, although it remained rather small. The experiments suggest a dipole-oriented incorporation of the porins into the lipid bilayer with a preference for the less strongly charged periplasmic surface entering first. The reported asymmetries were observed at low voltages of 2053 mV and therefore differ from the asymmetric voltage gating effects of natural or slightly mutated porins occurring at higher voltages (Morgan et al., 1990
| Notes |
|---|
1 To whom correspondence should be addressed. E-mail: schulz{at}bio.chemie.uni-freiburg.de
| Acknowledgments |
|---|
The conductivity measurements were performed in the laboratory of J.Weckesser. We thank R.Harwardt and J.Weckesser for their help and for discussions. The project was supported by contract BEO-BMBF no. 0310898.
| References |
|---|
|
|
|---|
Benz,R. and Bauer,K. (1988) Eur. J. Biochem., 176, 119.[Web of Science][Medline]
Brünger,A.T., Adams,P.D., Clore,G.M., DeLano,W.L., Gros,P. Grosse-Kunstleve,R.W., Jiang,J.-S., Kuszewski,J., Nilges,M., Pannu,N.S. et al. (1998) Acta Crystallogr. Sect. D, 54, 905921.[CrossRef][Medline]
Butz,S., Benz,R., Wacker,T., Welte,W., Lustig,A., Plapp,R. and Weckesser,J. (1993) Arch. Microbiol., 159, 301307.
CCP4: Collaborative Computational Project, Number 4. (1994) Acta Crystallogr. Sect. D, 50, 760763.[CrossRef][Medline]
Dahan,D., Vachon,V., Laprade,R. and Coulton,J.W. (1994) Biochim. Biophys. Acta, 1189, 204211.[Medline]
delaVega,A.L. and Delcour,A.H. (1995) EMBO J., 14, 60586065.[Web of Science][Medline]
Gokce,I., Bainbridge,G. and Lakey,J.H. (1997) FEBS Lett., 411, 201205.[CrossRef][Web of Science][Medline]
Hanahan,D. (1983) J. Mol. Biol., 166, 557580.[Web of Science][Medline]
Jap,B.K. and Walian,P.J. (1990) Q. Rev. Biophys., 23, 367403.[Web of Science][Medline]
Kreusch,A. and Schulz,G.E. (1994) J. Mol. Biol., 243, 891905.[CrossRef][Web of Science][Medline]
Kreusch,A., Neubüser,A., Schiltz,E., Weckesser,J. and Schulz,G.E. (1994) Protein Sci., 3, 5863.[Web of Science][Medline]
Leslie,A.G.W. (1999) Acta Crystallogr. Sect. D, 55, 16961702.[CrossRef][Medline]
Liu,N., Samartzidou,H., Lee,K.W., Briggs,J.M. and Delcour,A.H. (2000) Protein Eng., 13, 491500.
Mathes,A. and Engelhardt,H. (1998) Biophys. J., 75, 12551262.[Medline]
Montal,M. and Mueller,P. (1972) Proc. Natl Acad. Sci. USA, 69, 35613566.
Morgan,H., Lonsdale,J.T. and Alder,G. (1990) Biochim. Biophys. Acta, 1021, 175181.[Medline]
Nikaido,H. (1994) J. Biol. Chem., 269, 39053908.
Pautsch,A., Vogt,J., Model,K., Siebold,C. and Schulz,G.E. (1999) Proteins, 34, 167172.[CrossRef][Web of Science][Medline]
Rink,T., Bartel,H., Jung,G., Bannwarth,W. and Boheim,G. (1994) Eur. Biophys. J., 23, 155165.[CrossRef][Web of Science][Medline]
Samartzidou,H. and Delcour,A.H. (1998) EMBO J., 17, 93100.[CrossRef][Web of Science][Medline]
Saxena,K., Drosou,V., Maier,E., Benz,R. and Ludwig,B. (1999) Biochemistry, 38, 22062212.[CrossRef][Medline]
Schmid,B., Krömer,M. and Schulz,G.E. (1996) FEBS Lett., 381, 111114.[CrossRef][Web of Science][Medline]
Schmid,B. Maveyraud,L. Krömer,M. and Schulz,G.E. (1998) Protein Sci., 7, 16031611.[Web of Science][Medline]
Schulz,G.E. (1996) Curr. Opin. Struct. Biol., 6, 485490.[CrossRef][Web of Science][Medline]
Van Gelder,P., Saint,N., van Boxtel,R., Rosenbusch,J.P. and Tommassen,J. (1997) Protein Eng., 10, 699706.
Van Gelder,P., Dumas,F. and Winterhalter,M. (2000) Biophys. Chem., 85, 153167.[CrossRef][Web of Science][Medline]
Yeates,T.O. (1997) Methods Enzymol., 276, 344358.[Web of Science][Medline]
Zhou,M., Morais-Cabral,J.H., Mann,S. and MacKinnon,R. (2001) Nature, 411, 657661.[CrossRef][Medline]
Received September 27, 2001; revised June 25, 2002; accepted July 3, 2002.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



(solid) and 3


